VACCINATION AGAINST THE HPV POSSIBLE PRIMARY PREVENTION FOR NEOPLASIA

Revista Romana de PEDIATRIE | Volumul LXII, Nr. 4, An 2013

ISSN 1454-0398 | e-ISSN 2069-6175
ISSN-L 1454-0398
DOI: 10.37897/RJP

National Awards “Science and Research”

NEW! RJP has announced the annually National Award for "Science and Research" for the best scientific articles published throughout the year in the official journal.

ICMJE- Recommendations

Read the Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly work in Medical Journals.

Promoting Global Health

The published medical research literature is a global public good. Medical journal editors have a social responsibility to promote global health by publishing, whenever possible, research that furthers health worldwide.

Raluca Gabriela Ioan, Gabriela Adriana Dincă and Mioara Ionescu

ABSTRACT

The frequency of different types of cancer (among which the cervical cancer covers 55%) etiologically correlated with the Human Papillomavirus (HPV) infection is worrying particularly amongst early ages. Demonstrating the presence and the oncogene role of some HPV types opened the way to prophylaxis by vaccination in a significantly high percentage of cases. Vaccination against HPV was first used in 2006 and it remarkably brought down the infection prevalence, with a good immunologic response and durable protection.

Key words: papillomavirus, cancer, vaccination

Full text | PDF